Continuing Education - Real-World Perspectives in Managing CLL Treatment

Management options for chronic lymphocytic leukemia (CLL) have expanded in recent years. The emergence of new immunotherapeutic and targeted agents for both the first-line and relapsed/refractory settings—though of course beneficial for CLL patients—represents a challenge to clinicians, who must navigate the indicated uses, mechanisms of action, and toxicity profiles of these new agents. In determining optimal treatment plans, clinicians are also confronted with significant advances in the use of cytogenetic and molecular tests to stratify risk and determine prognosis. This interactive activity presents the points of view of healthcare professionals and patients on issues relating to current challenges in CLL care. Each point of view is followed by a brief discussion that will help oncologists, hematologist-oncologists, and other healthcare professionals who care for patients with CCL select the most appropriate targeted therapies, taking into account patient genetics, treatment adverse events, and previous treatments. The patient component, Chronic Lymphocytic Leukemia (CLL) High-Impact Topics: Testing, Targeted Treatment, and Side Effects, is hosted on LRF’s YouTube channel and is also available within the activity itself, along with a flyer explaining the piece, with the hope that HCPs who participate in the activity will view the HIT and see it as a useful resource for patients. This course can be accessed at